Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Update: A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab [Phase 3]
Phase 3 trial evaluating atezolizumab with lenvatinib or sorafenib versus lenvatinib or sorafenib alone in unresectable hepatocellular carci…
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Update: A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma [Phase 3]
Phase 3 trial investigating nivolumab in combination with ipilimumab for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer [Phase 2]
Phase 2 trial results for 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT in early detection of hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Update: MANDARIN (S6371) [Phase 3]
Phase 3 Clinical Trial update for MANDARIN (S6371) in inoperable hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Update: A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma [Phase 3]
Phase 3 trial update for Nofazinlimab (CS1003) in advanced hepatocellular carcinoma; trial status ACTIVE_NOT_RECRUITING with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Update: A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma [Phase 3]
Phase 3 trial evaluating TACE with durvalumab and bevacizumab in locoregional hepatocellular carcinoma is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-07-14Clinical Trial Results: A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Pexa-Vec (JX-594) given before Sorafenib for unresectable primary hepatocellular carcinoma has completed w…
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib [Phase 2]
Phase 2b trial evaluating Modified Vaccinia Virus in patients with advanced hepatocellular carcinoma who progressed on sorafenib has complet…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Clinical trial results in Zambian HIV-HBV co-infected patients evaluated liver fibrosis outcomes; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety and bioactivity of the ipilimumab and nivolumab combination in patients with hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004) [Phase 2]
Phase 2 trial evaluating safety and efficacy of coformulated pembrolizumab/quavonlimab with lenvatinib in advanced hepatocellular carcinoma;…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC [Phase 2]
Phase 2 trial comparing LOC (local/regional) therapy versus systemic therapy in patients with BCLC stage B hepatocellular carcinoma; study t…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: AFPᶜ³³²T in Advanced HCC [Phase 1]
Phase 1 clinical trial results for AFPc33 in advanced hepatocellular carcinoma and AFP-expressing tumors have been completed with results po…
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating atezolizumab and bevacizumab in unresectable hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere [Phase 3]
Phase 3 clinical trial evaluating TareSphere for unresectable hepatocellular carcinoma; currently active not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: MANDARIN (S6371) [Phase 3]
Phase 3 clinical trial update for MANDARIN (S6371) in inoperable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma [Phase 3]
Phase 3 trial evaluating TACE combined with atezolizumab plus bevacizumab versus TACE alone in untreated hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937) [Phase 3]
Phase 3 trial MK-3475-937 (KEYNOTE-937) evaluated pembrolizumab versus placebo as adjuvant therapy in hepatocellular carcinoma after complet…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC [Phase 2]
A prospective, randomized Phase 2 trial evaluating transarterial chemoembolization with a triple-immunotherapy regimen (sintilimab, bevacizu…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC [NA]
The document updates a safety and efficacy study of lenvatinib combined with VIC-1911 for advanced hepatocellular carcinoma. The trial is cu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
A prospective evaluation of a locked risk-stratified surveillance strategy for detecting extrahepatic metastasis in hepatocellular carcinoma…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
A completed clinical trial update examining whether Hepatitis B and Hepatitis C infections are risk factors for hepatocellular carcinoma amo…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant [Phase 2]
A Phase 2 trial evaluating lenvatinib for recurrent hepatocellular carcinoma after liver transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 study evaluating conversion therapy with hepatic arterial infusion chemotherapy (HAIC), lenvatinib, and cadonilimab for initially un…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC [NA]
Clinical trial update shows the study of lenvatinib plus VIC-1911 in lenvatinib-resistant hepatocellular carcinoma has been terminated.